Christopher J. H. Porter

ORCID: 0000-0003-3474-7551 · 3 papers in corpus
lab-animal 2012
Molecular pharmaceutics ·doi:10.1021/mp300298z

The purpose of the current study was to provide a mechanistic basis for in vitro and in vivo performance differences between lipid-based formulations solidified by adsorption onto a high surface area material and their respective liquid (i.…

lab-animal 2007
Journal of pharmaceutical sciences ·doi:10.1002/jps.21246

Lipid-based formulations of danazol with varying quantities of included surfactant have been examined in vitro and in vivo. Formulations comprising fatty acid ester surfactants were readily hydrolysed during in vitro digestion, although Cre…

lab-animal 2007
Pharmaceutical research ·doi:10.1007/s11095-006-9194-z

PURPOSE: To investigate the impact of a change in the proportions of lipid, surfactant and co-solvent on the solubilisation capacity of self-emulsifying formulations of danazol during in vitro dispersion and digestion studies and correlatio…